Science news articles about 'chronic lymphocytic leukaemia'

... . The investigators have identified a unique 'signature' or pattern of a specific family of enzymes in patients with chronic lymphocytic leukaemia (CLL), the most common form of adult leukaemia...

A drug once dismissed as ineffective in patients with chronic lymphocytic leukaemia (CLL) has shown promising results in two phase I and II clinical trials, according to ...

... . They found that high levels of a particular enzyme in the blood are an indicator that chronic lymphocytic leukaemia (CLL) - the most common form of adult leukaemia - will be aggressive and in need ...

A national team of researchers led by Mayo Clinic has found that patients with chronic lymphocytic leukaemia (CLL) are more likely to have similar DNA changes or variants in up to six genes, compared ...

... (EGCG), an active ingredient in green tea. The trial determined that patients with chronic lymphocytic leukaemia (CLL) can tolerate the chemical fairly well when high doses are administered in ...

... as a medicine, Campath-1H, now known as alemtuzumab. It has been licensed for the treatment of chronic lymphocytic leukaemia, and has also been tested in several diseases where the immune system is ...

The oral medication lenalidomide is safe and well-tolerated for elderly patients with chronic lymphocytic leukaemia, a group without a well-defined frontline therapy for their disease, researchers ...